In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, especially in patients with obesity.

Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...

We came across a bullish thesis on MoonLake Immunotherapeutics on Valueinvestorsclub.com by skimmer610. In this article, we ...

GLP-1 RA therapy reduces hidradenitis suppurativa severity, flares, symptoms, and BMI in patients with hidradenitis ...

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental ...

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Study Overview: Incyte Corporation is conducting a Phase ...

Explore how hidradenitis suppurativa is linked to increased rates of depression and anxiety, with no clear connection to ...

König A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999;198 (3):261-264. doi:10.1159/000018126 ...

Finally, it’s also important to pay attention to your mental health when you have hidradenitis suppurativa; people with HS have a higher risk of depression, anxiety, and low self-esteem.

Hidradenitis suppurativa generally causes inflamed, discolored, swollen bumps that can fill with pus and break open. Sometimes, the condition can also cause scarring and tunneling under your skin.